Роль коагулазонегативных стафилококков в патологии человека (обзор литературы)
Аннотация
Коагулазонегативные стафилококки (КНС) относятся к числу наиболее часто выявляемых бактерий при рутинной клинической диагностике. За последние десятилетия заболеваемость, связанная с КНС, значительно выросла. Многие КНС являются представителями нормальной микрофлоры кожи и слизистых оболочек человека: S. epidermidis, S. haemolyticus, S. hominis, S. warneri, S. xylosis, S. capitis, S. simulans, S. pettenkoferi и др. Долгое время их было принято рассматривать как бактерии–комменсалы, которые не продуцируют факторы вирулентности и имеют ограниченное значение в клинической практике. Однако накопленные в литературе данные свидетельствуют об их патогенности для человека и животных и роли как возбудителей инфекций, связанных с иммунодефицитами, имплантированными медицинскими устройствами, внутрисосудистыми катетерами. КНС выделяются среди пациентов отделений реанимации, хирургии, трансплантологии, ожоговых, неонатологических и других профилей. Также установлена их роль в качестве ведущих возбудителей нозокомиальных инфекций и как резервуаров генов резистентности к антибактериальным препаратам. Несмотря на увеличивающееся число сообщений об участии КНС в патологии человека, эта группа стафилококков остается недостаточно изученной.
Об авторах
О. Н. Огиенко
ФБУН Хабаровский НИИ эпидемиологии и микробиологии Роспотребнадзора, г. Хабаровск, Российская Федерация
Россия
Россия
Огиенко Ольга Николаевна – младший научный сотрудник лаборатории бактериальных инфекций
А. П. Бондаренко
ФБУН Хабаровский НИИ эпидемиологии и микробиологии Роспотребнадзора, г. Хабаровск, Российская Федерация
Россия
Россия
О. Е. Троценко
ФБУН Хабаровский НИИ эпидемиологии и микробиологии Роспотребнадзора, г. Хабаровск, Российская Федерация
Россия
Россия
Список литературы
1. Акатов А.К., Зуева В.С. Стафилококки. - М.: Медицина, 1983. – 255 с.
2. Баранцевич Н.Е., Баранцевич Е.П. Видовое разнообразие и метициллинорезистентность стафилококков при нозокомиальных инфекциях // КМАХ. – 2019. – Т. 21, № 3. – С. 207–211.
3. Беляева Е.В., Ермолина Г.Б., Борискина Е.В. и др. Мониторинг биопленкообразующей способности у циркулирующих в детском стационаре коагулазонегативных стафилококков // Медицинский альманах. – 2018. – Т. 4, № 55. – С. 26–30.
4. Бестужева Г.Р., Сабодаха М.А, Садыбакасова Г.К. Эволюционизирующий пейзаж коагулазоотрицательных стафилококков клинического происхождения // Вестник Кыргызско-Российского славянского университета. – 2018. – Т. 18, № 9. – С. 121–124.
5. Горелова Л.А., Царева В.В., Витович М.В. Цефтаролин против стафилококка и других супербактерий // Журнал микробиол. – 2017. - № 5. – С. 113–9.
6. Гостев В.В., Калиногорская О.С., Круглов А.Н., Сидоренко В.С. Антибиотикорезистентность коагулазоотрицательных стафилококков, выделенных в стационарах Санкт-Петербурга и Москвы // Антибиотики и химиотерапия. – 2015. – Т. 60, № 9–10. – С. 23–28.
7. Карабах В.И. Микробиологический мониторинг за возбудителями нозокомиальных инфекций // Антибиотики и химиотерапия. – 2000. – Т. 43, № 3. – С. 20–23.
8. Козлова Ю.Н., Фоменко Н.В., Морозова В.В. и др. Генетическая и биохимическая характеризация стафилококков, встречающихся в Новосибирске // Вавиловский журнал генетики и селекции. – 2017. – Т. 21, № 8. – С. 952–958.
9. Любасовская Л.А., Корниенко М.А., Припутневич Т.В., Ильина Е.Н., Щеголев А.И. Микробиологическая и молекулярно-генетическая характеристика коагулазонегативных стафилококков, выделенных у новорождённых отделения реанимации и интенсивной терапии // Антибиотики и химиотерапия. – 2013. – Т. 58, № 3–4. – С. 25–32.
10. Покровский В.И., Акимкин В.Г., Брико Н.И. и др. Национальная концепция профилактики инфекций, связанных с оказанием медицинской помощи, и информационный материал по ее положениям / Нижний Новгород: Ремедиум Приволжье, 2012. – 84 с.
11. Савельева В.С. Хирургические инфекции кожи и мягких тканей: Российские национальные рекомендации. – М, 2009. – 89 с.
12. Трубачева Е.С. Коагулазонегативные стафилококки // https://www.vidal.ru/vracham/antibiotikoterapiya/staphylococci/koagulazonegativnye-stafilokokki
13. Шайхразиева Н.Д., Булычева И.А., Лопушов Д.В., Сабаева Ф.Н. Этиологическая структура и антибиотикорезистентность госпитальных штаммов микроорганизмов в отделении анестезиологии и реанимации // Медицинский альманах. – 2019. – Т. 1, № 58. – С. 32–34.
14. AlDhaleei W.A., Bhagavathula A.S., Aldoghaither R. Embolic Stroke and Meningitis Secondary to Staphylococcus lugdunensis Native Valve Endocarditis // Case Rep Infect Dis. – 2019. https://doi.org/10.1155/2019/7910262.
15. Anguera I., Del Río A., Miró J.M. et al. Hospital Clinic Endocarditis Study Group. Staphylococcus lugdunensis infective endocarditis: description of 10 cases and analysis of native valve, prosthetic valve, and pacemaker lead endocarditis clinical profiles // Heart. – 2005. – Vol. 91, № 2. – P. 10.
16. Announ N., Mattei J.P., Jaoua S. et al. Multifocal discitis caused by Staphylococcus warneri // Joint Bone Spine. – 2004. – Vol. 71, № 3. – P. 240–242.
17. Antonello R.M., Principe L., Maraolo A.E. et al. Fosfomycin as Partner Drug for Systemic Infection Management. A Systematic Review of Its Synergistic Properties from In Vitro and In Vivo Studies // Antibiotics (Basel). - 2020. – Vol. 9, № 8. – P. 500.
18. Ayeni F.A., Andersen C., Nørskov-Lauritsen N. Comparison of growth on mannitol salt agar, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, VITEK 2 with partial sequencing of 16S rRNA gene for identification of coagulase-negative staphylococci // Microb Pathog. – 2017. – Vol. 105. – P. 255–259.
19. Azimi T., Mirzadeh M., Sabour S. et al. Coagulase-negative staphylococci (CoNS) meningitis: a narrative review of the literature from 2000 to 2020 // New Microbes New Infect. – 2020. – Vol. 37:100755.
20. Banaszkiewicz S., Calland J.K., Mourkas E. et al. Genetic Diversity of Composite Enterotoxigenic Staphylococcus epidermidis Pathogenicity Islands // Genome Biol Evol. – 2019. – Vol. 11, № 12. – P. 3498–3509.
21. Becker K., Both A., Weißelberg S. et al. Emergence of coagulase-negative staphylococci // Expert Rev Anti Infect Ther. – 2020. – Vol. 18, № 4. – P. 349–366.
22. Becker K., Harmsen D., Mellmann A. et al. Development and evaluation of a quality-controlled ribosomal sequence database for 16S ribosomal DNA-based identification of Staphylococcus species // J Clin Microbiol. – 2004. – Vol. 42, № 11. – P. 4988–4995.
23. Becker K., Heilmann C., Peters G. Coagulase-negative staphylococci // Clin Microbiol Rev. – 2014. – Vol. 27, № 4. – P. 870–926.
24. Berti A.D., Harven L.T., Bingley V. Distinct Effectiveness of Oritavancin against ToleranceInduced Staphylococcus aureus // Antibiotics (Basel). – 2020. – Vol. 9, № 11. – P. 789.
25. Bouiller K., Ilic D., Wicky P.H. et al. Spread of clonal linezolid-resistant Staphylococcus epidermidis in an intensive care unit associated with linezolid exposure // Eur J Clin Microbiol Infect Dis. – 2020. Vol. 39, № 7. – P. 1271–1277.
26. Bush L.M., MD, FACP et al. Staphylococcal Infections / Last review, 2021. https://www.msdmanuals.com/professional/infectious-diseases/gram-positive-cocci/staphylococcalinfections.
27. Cameron D.R., Jiang J.H., Hassan K.A. et al. Insights on virulence from the complete genome of Staphylococcus capitis // Front Microbiol. – 2015. – Vol. 6. – P. 980.
28. Chang W.N., Lu C.H., Huang C.R., Chuang Y.C. Mixed infection in adult bacterial meningitis // Infection. – 2000. – Vol. 28, № 1. – P. 8–12.
29. Cherniy V.I., Kolesnikov A.N., Kuznetsova I.V. Antibiotic therapy in emergency medicine / Donetsk: Zaslavsky Publ, 2010.
30. Choi S.H., Choi S.H. Predictive performance of serum procalcitonin for the diagnosis of bacterial meningitis after neurosurgery // Infect Chemother. – 2013. – Vol. 45, №3. – P. 308–314.
31. Cole K., Atkins B., Llewelyn M., Paul J. Genomic investigation of clinically significant coagulasenegative staphylococci // J Med Microbiol. – 2021. - Vol. 70, № 3.
32. Conlan S., Mijares L.A., NISC Comparative Sequencing Program et al. Staphylococcus epidermidis pan-genome sequence analysis reveals diversity of skin commensal and hospital infectionassociated isolates // Genome Biol. – 2012. – Vol. 13, № 7. – P. 64.
33. Cynamon M.H., Granato P.A. Comparison of the in vitro activities of teichomycin A2 and vancomycin against staphylococci and enterococci // Antimicrob Agents Chemother. – 1982. – Vol.21, №3. – P. 504–505.
34. Czekaj T., Ciszewski M., Szewczyk E.M. Staphylococcus haemolyticus - an emerging threat in the twilight of the antibiotics age // Microbiology (Reading). – 2015. – Vol.161, №11. – P. 2061–2068.
35. Da Costa T.M., Cuba G.T., Morgado P.G.M. et al. Pharmacodynamic comparison of different antimicrobial regimens against Staphylococcus aureus bloodstream infections with elevated vancomycin minimum inhibitory concentration // BMC Infect Dis. – 2020. – Vol.20, №1. – P. 74.
36. Decousser J.W., Desroches M., Bourgeois-Nicolaos N. et al. Susceptibility trends including emergence of linezolid resistance among coagulase-negative staphylococci and meticillin-resistant Staphylococcus aureus from invasive infections // Int J Antimicrob Agents. – 2015. – Vol.46, №6. – P. 622–630.
37. Doichinova T.G., Gancheva G.I., Totsev N.I. Staphylococcal meningitis: review of five cases // J Med Res. – 2014. – P. 1–4.
38. Drinkovic D., Pottumarthy S., Knight D., Morris A.J. Neonatal coagulase-negative staphylococcal meningitis: a report of two cases // Pathology. – 2002. – Vol.34, №6. – P. 586-588.
39. El Nakadi N., El Nakadi B. Native valve endocarditis caused by Staphylococcus warneri: an unusual presentation. // Acta Cardiol. – 2021. – Vol.76, №3. – P. 318-319.
40. Espadinha D., Sobral R.G., Mendes C.I. et al. Distinct Phenotypic and Genomic Signatures Underlie Contrasting Pathogenic Potential of Staphylococcus epidermidis Clonal Lineages // Front Microbiol. – 2019. – Vol.10. – P. 1971.
41. Fairbrother R.W. Coagulase production us a crite¬rion for the classification of the staphylococcus // J. Pathol., bacterial. – 1940. – № 50. P. 83–88.
42. Freney J., Brun Y., Bes M. et al. Staphylococcus lugdunensis sp. nov and Staphylococcus schleiferi sp. nov., two species from human clinical specimens // Int J Syst Evol Microbiol. – 1988. –№ 38. – P. 168–172.
43. Garg R.K., Malhotra H.S., Jain M. et al. Brainstem infarct as a rare complication of coagulasenegative Staphylococcus meningitis // Neurol India. – 2017. – № 65. – P. 621–623.
44. Gianella S., Ulrich S., Huttner B., Speich R. Conservative management of a brain abscess in a patient with Staphylococcus lugdunensis endocarditis // Eur J Clin Microbiol Infect Dis. – 2006. – №25. – P. 476–478.
45. Giormezis N., Kolonitsiou F., Foka A. et al. Coagulase-negative staphylococcal bloodstream and prosthetic-device-associated infections: the role of biofilm formation and distribution of adhesin and toxin genes // J Med Microbiol. – 2014. – Vol. 63, № 11. – P. 1500-1508.
46. Gray D.A. Wenzel M. More Than a Pore: A Current Perspective on the In Vivo Mode of Action of the Lipopeptide Antibiotic Daptomycin // Antibiotics. – 2020. – Vol. 9, № 1. – P. 17.
47. Grice EA. The skin microbiome // Nat Rev Microbiol. – 2011. – Vol. 9, № 4. – P. 244–253.
48. Gu B., Kelesidis T., Tsiodras S. et al. The emerging problem of linezolid-resistant Staphylococcus // J. Antimicrob. Chemother. – 2013. – Vol. 68. – P. 4–11.
49. Habib G., Lancellotti P., Antunes M.J. et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM) // Eur. Heart J. – 2015. – Vol. 36. – P. 3075–3128.
50. Høiby N., Bjarnsholt T., Moser C. et al. ESCMID guideline for the diagnosis and treatment of biofilm infections 2014 // Clin Microbiol Infect. – 2015. – Vol. 21, № 1. – P. 1-25.
51. Incani R.N., Hernández M., Cortez J. et al. Staphylococcus warneri meningitis in a patient with Strongyloides stercoralis hyperinfection and lymphoma: first report of a case // Rev Inst Med Trop Sao Paulo. – 2010. – № 52. – P. 169–170.
52. Iversen K., Ihlemann N., Gill S.U. et al. Partial Oral versus Intravenous Antibiotic Treatment of Endocarditis // N. Engl. J. Med. – 2019. – № 380. – P. 415–424.
53. Jiang H., Su M., Kui L. et al. Prevalence and antibiotic resistance profiles of cerebrospinal fluid pathogens in children with acute bacterial meningitis in Yunnan province, China, 2012–2015 // PLoS One. – 2017. – Vol. 12, № 6.
54. Joubert I.A., Otto M., Strunk T., Currie A.J. Look Who's Talking: Host and Pathogen Drivers of Staphylococcus epidermidis Virulence in Neonatal Sepsis // Int J Mol Sci. – 2022. – Vol. 23, № 2. – P. 860.
55. Jung Y.J., Chang M.C. Bacterial meningitis and cauda equina syndrome after transsacral epiduroscopic laser decompression: a case report // Medicine. – 2019. – Vol. 98, № 11. – P. 1–3.
56. Kaabia N., Scauarda D., Lena G., Drancourt M. Molecular identification of Staphylococcus lugdunensis in a patient with meningitis // J Clin Microbiol. – 2002. – Vol. 40. – P. 1824–1825.
57. Kamath U., Singer C., Isenberg H.D. Clinical significance of Staphylococcus warneri bacteremia // J Clin Microbiol. – 1992. – Vol. 30. – P. 261–264.
58. Kerschner H., Cabal A., Hartl R. et al. Hospital outbreak caused by linezolid resistant Enterococcus faecium in Upper Austria // Antimicrob. Resist. Infect. Control. – 2019. – Vol. 8. – P. 150.
59. Kessler R.B., Kimbrough R.C., Jones S.R. III Infective endocarditis caused by Staphylococcus hominis after vasectomy // Clin Infect Dis. – 1998. – Vol. 27. – P. 216–217.
60. Kloos W.E., Schleifer K.H. Isolation and characterization of staphylococci from human skin II. Descriptions of four new species: Staphylococcus warneri, Staphylococcus capitis, Staphylococcus hominis, and Staphylococcus simulans // Int J Syst Evol Microbiol. – 1975. – Vol. 25. – P. 62–79.
61. Kosecka-Strojek M., Ilczyszyn W.M., Buda A. et al. Multiple-locus variable-number tandem repeat fingerprinting as a method for rapid and cost-effective typing of animal-associated Staphylococcus aureus strains from lineages other than sequence type 398 // J Med Microbiol. – 2016. – Vol. 65, № 12. – P. 1494–1504.
62. Kosecka-Strojek M., Sabat A.J., Akkerboom V. et al. Development and validation of a reference data set for assigning staphylococcus species based on next-generation sequencing of the 16S-23S rRNA region // Front Cell Infect Microbiol. – 2019. – Vol. 9. – P. 278.
63. Kosecka-Strojek M., Sabat A.J., Akkerboom V. et al. Development of a reference data set for assigning Streptococcus and Enterococcus species based on next generation sequencing of 16S–23S rRNA region // Antimicrob Resist Infect Control. – 2019. – Vol. 8. – P. 178.
64. Kosecka-Strojek M., Sadowy E., Gawryszewska I. et al. Emergence of linezolid-resistant Staphylococcus epidermidis in the tertiary children’s hospital in Cracow, Poland // Eur. J. Clin. Microbiol. Infect. Dis. – 2020. – Vol. 39.
65. Kramer T.S., Schwab F., Behnke M. et al. Linezolid use in German acute care hospitals: Results from two consecutive national point prevalence surveys // Antimicrob. Resist. Infect. Control. – 2019. – Vol. 8. – P. 159.
66. Kushwaha M.P., Najarro R.V. An epidemiologic and microbiologic profile of children aged 0–59 months admitted with suspected meningitis in VSMMC, Cebu, Philippines // Pediatrics. – 2017. – Vol. 6. – P. 1743–1747.
67. Lai W.A., Chen S.F., Tsai N.W. et al. Clinical characteristics and prognosis of acute bacterial meningitis in elderly patients over 65: a hospital-based study // BMC Geriatr. – 2011. – Vol. 11. – P. 91–96.
68. Lee J.J., Lien C.Y., Huang C.R. et al. Clinical characteristics and therapeutic outcomes of postneurosurgical bacterial meningitis in elderly patients over 65: a hospital-based study // Acta Neurol. – 2017. – Vol. 26. – P. 144–153.
69. LisowskaŁysiak K., Kosecka-Strojek M., Białecka J. et al. New insight into genotypic and phenotypic relatedness of Staphylococcus aureus strains from human infections or animal reservoirs // Pol J Microbiol. – 2019. – Vol. 68, № 1. – P. 93–104.
70. Li Y.M., Blaskiewicz D.J., Hall W.A. Shunt-related intracranial abscess caused by Staphylococcus lugdunensis in a hydranencephalic patient // World Neurosurg. – 2013. – Vol. 80. – P. 387–389.
71. Li Z., Wu X., Yu J. et al. Empirical combination antibiotic therapy improves the outcome of nosocomial meningitis or ventriculitis in neurocritical care unit patients // Surg Infect. – 2016. – Vol. 17. – P. 465–472.
72. Lin S., Sun B., Shi X. et al. Comparative genomic and pan-genomic characterization of Staphylococcus epidermidis from different sources unveils the molecular basis and potential biomarkers of pathogenic strains // Front Microbiol. – 2021. – Vol. 12. – P. 1–14.
73. Lin W.S., Kao H.W., Cheng C.A. Panspinal epidural abscess concomitant with meningitis // Am J Emerg Med. – 2013. – Vol. 31, № 7. – P. 1155.e5–1155.e6.
74. Maarouf L., Omar H., El-Nakeeb M., Abouelfetouh A. Prevalence and mechanisms of linezolid resistance among staphylococcal clinical isolates from Egypt // Eur. J. Clin. Microbiol. Infect. Dis. – 2020. – Vol. 40. – P. 815–823.
75. Matas A., Veiga A., Gabriel J.P. Brain abscess due to Staphylococcus lugdunensis in the absence of endocarditis or bacteremia // Case Rep Neurol. – 2015. – Vol. 7. – P. 1–5.
76. Matrat L., Plaisant F., Barreto C. et al. Increasing use of linezolid in a tertiary NICU during a 10-year period: Reasons and concerns for the future // Antimicrob. Resist. Infect. Control. – 2020. – Vol. 9. – P. 156.
77. McCormick M.H., McGuire J.M., Pittenger G.E. et al. Vancomycin, a new antibiotic. I. Chemical and biologic properties // Antibiot. Annu. – 1955. – Vol. 3. – P. 606–611.
78. McNally M., Sousa R., Wouthuyzen-Bakker M. et al. The EBJIS definition of periprosthetic joint infection: a practical guide for clinicians // Bone Jt J. – 2021. – Vol. 103. – № 1. – P. 18–25.
79. Michalik M., Samet A., Podbielska-Kubera A. et al. Coagulase-negative staphylococci (CoNS) as a significant etiological factor of laryngological infections: a review // Ann Clin Microbiol Antimicrob. – 2020. – Vol. 19, № 26. – P. 1–10.
80. Moawad A.A., Hotzel H., Awad O. et al. Evolution of Antibiotic Resistance of CoagulaseNegative Staphylococci Isolated from Healthy Turkeys in Egypt: First Report of Linezolid Resistance // Microorganisms. – 2019. – Vol. 7, № 476.
81. Mounier R., Lobo D., Hulin A. et al. Is first-line vancomycin still the best option to treat Staphylococcus health care–associated meningitis? // World Neurosurg. – 2017. – Vol. 99. – P. 812.e1–812.e5.
82. Nguyen T.H., Park M.D., Otto M. Host Response to Staphylococcus epidermidis Colonization and Infections // Front Cell Infect Microbiol. – 2017. – Vol. 7. – P. 90.
83. Noshak M.A., Rezaee M.A., Hasani A., Mirzaii M. The Role of the Coagulase-negative Staphylococci (CoNS) in Infective Endocarditis. A Narrative Review from 2000 to 2020 // Curr Pharm Biotechnol. – 2020. – Vol. 21, №12. – P. 1140-1153.
84. Osmon D.R., Berbari E.F., Berendt A.R. et al. Diagnosis and management of prosthetic joint infection: Clinical practice guidelines by the Infectious Diseases Society of America // Clin. Infect. Dis. – 2013. – Vol. 56. – P. 1–25.
85. Otto M. Staphylococcus epidermidis-the “accidental” pathogen // Nat Rev Microbiol. – 2009. – Vol. 7. – P. 555–567.
86. Otto M. Coagulase-negative staphylococci as reservoirs of genes facilitating MRSA infection: Staphylococcal commensal species such as Staphylococcus epidermidis are being recognized as important sources of genes promoting MRSA colonization and virulence // Bioessays. – 2013. – Vol. 35. – P. 4–11.
87. Otto M. Staphylococcus epidermidis pathogenesis // Methods in molecular biology (Clifton, N.J.). – 2014. – Vol. 1106. – P. 17–31.
88. Oud L. Community-acquired meningitis due to Staphylococcus capitis in the absence of neurologic trauma, surgery, or implants // Heart Lung. – 2011. – Vol. 40. – P. 467–471.
89. Paharik A.E., Horswill A.R. The Staphylococcal Biofilm: Adhesins, Regulation, and Host Response // Microbiology Spectrum. – 2016. – Vol. 4. – № 2. – P. 529–566.
90. Pfaller M.A., Mendes R.E., Duncan L.R. et al. Activity of dalbavancin and comparator agents against Gram-positive cocci from clinical infections in the USA and Europe 2015–16 // J. Antimicrob. Chemother. – 2018. – Vol. 73. – P. 2748–2756.
91. Prola K. Coagulase-negative staphylococci pathogenomics // Int J Mol Sci. –2019. – Vol. 20, № 5. – P. 1215.
92. Qin N., Ding W., Yao J. et al. Genome sequence of Staphylococcus capitis QN1, which causes infective endocarditis // Am Soc Microbiol. – 2012. – Vol. 194. – P. 4469–4470.
93. Rampelotto R.F., Lorenzoni V.V., Silva D.D.C. et al. Assessment of different methods for the detection of biofilm production in coagulase-negative staphylococci isolated from blood cultures of newborns // Rev Soc Bras Med Trop. – 2018. – Vol. 51, № 6. – P. 761–767.
94. Rasigade J.P., Raulin O., Picaud J.C. et al. Methicillin-resistant Staphylococcus capitis with reduced vancomycin susceptibility causes late-onset sepsis in intensive care neonates // PLoS One. – 2012. – Vol. 7.
95. Rosenbach F.J. Mikro-organismen bei den Wund-Infections-Krankheiten des Menschen / Wiesbaden: J.F. Bergmann, 1884.
96. Rupp M.E. Clinical characteristics of infections in humans due to Staphylococcus epidermidis // Methods Mol Biol. – 2014. – Vol. 1106. – P. 1–16.
97. Sabat A.J., Van Zanten E., Akkerboom V. et al. Targeted next-generation sequencing of the 16S-23S rRNA region for culture-independent bacterial identification- increased discrimination of closely related species // Sci Rep. – 2017. – Vol. 7. – P. 3434.
98. Sabe M.A., Shrestha N.K., Gordon S., Menon V. Staphylococcus lugdunensis: a rare but destructive cause of coagulase-negative Staphylococcus infective endocarditis // Eur Heart J Acute Cardiovasc Care. – 2014. – Vol. 3. – Vol. P. 275–280.
99. Sandoe J.A., Longshaw C.M. Ventriculoperitoneal shunt infection caused by Staphylococcus lugdunensis // Clin Microbiol Infect. – 2001. – Vol. 7. – P. 385–387.
100. Saravolatz L.D., Cleveland K.O., Rikabi K. et al. Real-world use of telavancin in the treatment of osteomyelitis // Diagn. Microbiol. Infect. Dis. – 2019. – Vol. 95. – P. 185–190.
101. Satlin M.J., Nicolau D.P., Humphries R.M. et al. Development of Daptomycin Susceptibility Breakpoints for Enterococcus faecium and Revision of the Breakpoints for Other Enterococcal Species by the Clinical and Laboratory Standards Institute // Clin. Infect. Dis. – 2020. – Vol. 70. – P. 1240–1246.
102. Shariati A., Dadashi M., Chegini Z. et al. The global prevalence of Daptomycin, Tigecycline, Quinupristin/Dalfopristin, and Linezolid-resistant Staphylococcus aureus and coagulase-negative staphylococci strains: A systematic review and meta-analysis // Antimicrob. Resist. Infect. Control. – 2020. – Vol. 9. – P. 56.
103. Shortridge D., Flamm R.K. Comparative In Vitro Activities of New Antibiotics for the Treatment of Skin Infections // Clin. Infect. Dis. – 2019. – Vol. 68, № 3. – P. 200–205.
104. Skovdal S.M., Jørgensen N.P., Meyer R.L. JMM Profile: Staphylococcus epidermidis // J Med Microbiol. – 2022. – Vol. 71, № 10.
105. Srinivasan L., Kilpatrick L., Shah S.S. et al. Cerebrospinal fluid cytokines in the diagnosis of bacterial meningitis in infants // Pediatr Res. – 2016. – Vol. 80. – P. 566–572.
106. Tian L., Zhang Z., Sun Z.Y. Pathogen analysis of central nervous system infections in a Chinese teaching hospital from 2012–2018: a laboratory-based retrospective study // Curr Med Sci. – 2019. – Vol. 39. – P. 449–454.
107. Tian R., Hao S., Hou Z. et al. The characteristics of post-neurosurgical bacterial meningitis in elective neurosurgery in 2012: a single institute study // Clin Neurol Neurosurg. – 2015. – Vol. 139. – P. 41–45.
108. The Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome // Nature. – 2012. – Vol. 486. – P. 207–214.
109. Theil C., Schmidt-Braekling T., Gosheger G. et al. Clinical use of linezolid in periprosthetic joint infections—A systematic review // J. Bone Jt. Infect. – 2020. – Vol. 6. – P. 7–16.
110. Tokars J.I. Predictive value of blood cultures positive for coagulase-negative staphylococci: implications for patient care and health care quality assurance // Clin Infect Dis. – 2004. – Vol. 39. – P. 333–341.
111. Trampuz A., Zimmerli W. Antimicrobial agents in orthopaedic surgery: prophylaxis and treatment // Drugs. – 2006. – Vol. 66. – P. 1089–1105.
112. Vijayan P., Srinivas D., Siddaiah N., Bahubali V.K. Device-associated meningitis by linezolidresistant Staphylococcus haemolyticus in a vancomycin-hypersensitive patient // J Neurosci Rural Pract. – 2019. – Vol. 10. – P. 718–720.
113. Watanabe S., Tanaka A., Ono T. et al. Treatment with linezolid in a neonate with meningitis caused by methicillin-resistant Staphylococcus epidermidis // Eur J Pediatr. – 2013. – Vol. 172. – P. 1419–1421.
114. Yadegarynia D., Gachkar L., Fatemi A. et al. Changing pattern of infectious agents in postneurosurgical meningitis // Caspian J Intern Med. – 2014. – Vol. 5. – P. 170–175.
115. Zhao Z., Hua X., Yu J. et al. Duration of empirical therapy in neonatal bacterial meningitis with third generation cephalosporin: a multicenter retrospective study // Arch Med Sci. – 2019. – Vol. 15. – P. 1482–1489.
116. Zheng Y., Hunt R.L., Villaruz A.E. et al. Commensal Staphylococcus epidermidis contributes to skin barrier homeostasis by generating protective ceramides // Cell Host Microbe. – 2022. – Vol. 30, № 3. – P. 301–313.
117. Zimmerli W., Trampuz A., Ochsner P.E. Prosthetic-joint infections // N Engl J Med. – 2004. – Vol. 351. – P. 1645–1654.
Рецензия
Для цитирования:
Огиенко О.Н., Бондаренко А.П., Троценко О.Е. Роль коагулазонегативных стафилококков в патологии человека (обзор литературы). Дальневосточный журнал инфекционной патологии. 2023;(44):99-114.
For citation:
Ogienko O.N., Bondarenko A.P., Trotsenko O.E. Role of coagulase-negative staphylococcus in human pathology: A literature review. Far Eastern Journal of Infectious Pathology. 2023;(44):99-114. (In Russ.)
Просмотров:
28
Послать статью по эл. почте 